At a Glance

• Multistate coalition of AGs enters $102.5 million settlement with Suboxone manufacturer
• Oregon AG announces investigation of Fox Corporation’s board of directors
• Connecticut AG opens investigation into automobile anti-theft technology
• Coalition of AGs submits comment on artificial intelligence accountability standards
• California AG obtains $3.8 million settlement in anti-kickback and False Claims Act investigation
• New York AG sues four nursing homes for financial fraud and resident neglect
• New York AG recovers $1.7 million from cryptocurrency platform operating illegally

Multistate Coalition of AGs Enters $102.5 Million Settlement With Suboxone Manufacturer

On June 2, 2023, the AGs of 41 states and Washington, D.C., filed a stipulation to resolve claims stemming from a 2016 lawsuit in which the AGs alleged that Virginia-based drug manufacturer Indivior had used anticompetitive tactics to illegally keep generic manufacturers out of the market and extend its monopoly on the opioid medication Suboxone. Specifically, the AGs alleged that Indivior had engaged in a practice known as “product hopping” by switching to an oral film version from a tablet version just as generic manufacturers were poised to begin marketing their own tablet versions.

The stipulation imposes disclosure requirements on Indivior when filing a citizen petition, filing a new drug application for a follow-on drug, beginning to market an FDA-approved drug, or for any change in corporate...

Read Full Story: https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3Lmpkc3VwcmEuY29tL2xl...